![Western Blot: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - Mouse brain tissue were subjected to SDS PAGE followed by western blot with (Suppression of Tumorigenicity 7 Antibody) at dilution of 1:2000](http://images.novusbio.com/fullsize/nbp3-45542_rabbit-suppression-of-tumorigenicity-7-pab-bsa-free-28420251257402.jpg "Western Blot: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - Mouse brain tissue were subjected to SDS PAGE followed by western blot with (Suppression of Tumorigenicity 7 Antibody) at dilution of 1:2000")
| Reactivity | Hu, MuSpecies Glossary |
| Applications | WB, ELISA, IHC, IP |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Immunogen | suppression of tumorigenicity 7. (Uniprot# Q9NRC1) |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | ST7 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Dilutions |
|
| Theoretical MW | 63 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| Storage | Store at -20C. Avoid freeze-thaw cycles. |
| Buffer | PBS, 50% Glycerol, pH (7.3) |
| Preservative | 0.02% Sodium Azide |
| Purity | Immunogen affinity purified |
![Wnt-2b Antibody [Unconjugated]](/sites/all/modules/enterprise-tech/et_datasheets/images/novus_guarantee.png "Wnt-2b Antibody [Unconjugated]")
Secondary Antibodies |
Isotype Controls |
Research Areas for Suppression of Tumorigenicity 7 Antibody (NBP3-45542)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
| Gene Symbol | ST7 |
![Immunohistochemistry: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - Immunohistochemistry of paraffin-embedded human liver using (Suppression of Tumorigenicity 7 antibody) at dilution of 1:50](http://images.novusbio.com/fullsize/nbp3-45542_rabbit-suppression-of-tumorigenicity-7-pab-bsa-free-284202513871.jpg "Immunohistochemistry: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - Immunohistochemistry of paraffin-embedded human liver using (Suppression of Tumorigenicity 7 antibody) at dilution of 1:50")
![Immunoprecipitation: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - IP Result of anti-Suppression of Tumorigenicity 7 (IP:, 4ug; Detection: 1:1500) with PC-3 cells lysate 2640ug.](http://images.novusbio.com/fullsize/nbp3-45542_rabbit-suppression-of-tumorigenicity-7-pab-bsa-free-28420251237136.jpg "Immunoprecipitation: Suppression of Tumorigenicity 7 Antibody - BSA Free [NBP3-45542] - IP Result of anti-Suppression of Tumorigenicity 7 (IP:, 4ug; Detection: 1:1500) with PC-3 cells lysate 2640ug.")
![Immunohistochemistry TSG Antibody [Unconjugated]](https://images.novusbio.com/images2/TSG_AF756_Immunohistochemistry_6896.jpg)
![Immunohistochemistry TSG Antibody [Unconjugated]](https://images.novusbio.com/images2/TSG_AF756_Immunohistochemistry_9970.jpg)
![N/A ST2/IL-33R [Biotin]](https://images.novusbio.com/images2/DATA_ST2_DY523_ELISA_2475.jpg)
![N/A ST2/IL-33R [Biotin]](https://images.novusbio.com/images2/DATA_ST2_DY523_ELISA_2088.jpg)
![Immunohistochemistry CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images2/CFTR_MAB25031_Immunohistochemistry_6973.jpg)
![Immunohistochemistry CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images2/CFTR_MAB25031_Immunohistochemistry_9671.jpg)
![Immunoprecipitation CFTR Antibody (24-1) [Unconjugated] - C-terminus](https://images.novusbio.com/images/mab25031_human-cftr-c-terminus-mab-clone-24-1-41202412513815.jpg)
![Western Blot RECK Antibody [Unconjugated]](https://images.novusbio.com/images2/RECK_AF1734_Western_Blot_17016.jpg)
![Immunocytochemistry FoxP2 Antibody [Unconjugated]](https://images.novusbio.com/images2/FoxP2_AF5647_Immunocytochemistry_6519.jpg)
![Western Blot FoxP2 Antibody [Unconjugated]](https://images.novusbio.com/images2/af5647_human-mouse-foxp2-affinity-purified-polyclonal-ab-western-blot-181220208498.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")